SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

Top Headlines

Strategic partnerships yet to fully catch on, Tufts report finds

Although a growing number of sponsors and CROs have managed strategic relationships for as many as five years, sponsors still rely on a mix of outsourcing approaches to tackle their clinical programs, according to a new report.

People on the Move

Movers and shakers in outsourcing

This week's round-up of who's going places in contract research, manufacturing and services.

Survey finds CROs far from going paperless with TMFs

Although the barriers for going paperless are relatively low for CROs, the service providers have yet to fully adopt electronic TMFs (trial master files), a new survey says.

Feature

Millionaire crowdfunding: the future of clinical trials?

A UK writer has described how his mission to start a trial for a therapeutic virus against his friend’s cancer has led to a new model of research funding which bypasses sponsors and CROs.

INC Research sets pricing for IPO at $150m

The Raleigh, North Carolina-based CRO INC Research plans to raise about $150m in its initial public offering via about 8.1m shares at a price range of $17 to $20 per share. 

Spotlight

ex-RPS CIO drops lawsuit after settling wrongful dismissal case

ex-RPS CIO drops wrongful dismissal lawsuit and allegations the CRO unlawfully stored applicant data

An ex RPS employee who claimed he was sacked after discovering the CRO was unlawfully storing potential...

Consort Medical to buy Aesica for £230m
update

Consort Medical cites growing Bespak as driver for £230m Aesica acquisition

Consort Medical will buy UK contractor Aesica for £230m from Silverfleet Capital in a deal announced today.

Medidata hit by $4.8m wire fraud, but says customer data is safe

Medidata hit by $4.8m wire fraud, but says customer clinical trial data is safe

Fraudsters who hoodwinked Medidata Solutions into transferring $4.8m to an "overseas" account this month did not access...

EMA opens investigation into India’s GVK Bio over ECG falsifications
Update

EMA opens investigation into India’s GVK Bio over ECG falsifications

At the request of the European Commission, the EMA (European Medicines Agency) announced Friday that it would...

AstraZeneca brings IT services in-house with new Indian facility

AstraZeneca brings IT services in-house with new Indian facility

The opening of a global IT centre in India will bring services back in-house, but AstraZeneca says...

Ukraine still attracting international trials according to new study

Ukraine still attracting Quintiles, PPD, Icon, Parexel and INC says study

Political instability in Ukraine has not diminished international drug industry desire to conduct clinical trials there according...